Pathophysiology and management of glaucoma and ocular hypertension related to trauma.
Razeghinejad Reza, Lin Michael M, Lee Daniel, Katz L Jay, Myers Jonathan S
AI Summary
Ocular trauma causes glaucoma through diverse mechanisms like blunt injury or inflammation; understanding these is crucial for proper management to prevent vision loss.
Abstract
Ocular trauma is a significant cause of blindness worldwide, particularly if associated with glaucoma. Direct damage from blunt or penetrating trauma, bleeding, inflammation, lens-related problems, orbital and brain vascular pathologies related to trauma, and chemical injuries may increase intraocular pressure and lead to traumatic glaucoma. Treatment may be as simple as eliminating the underlying cause in some conditions or management can be challenging, depending on the mechanism of damage. If proper management is not undertaken, visual outcomes can be poor. We discuss a broad spectrum of trauma-related mechanisms of intraocular pressure elevation, as well as their management.
MeSH Terms
Shields Classification
Key Concepts4
Ocular trauma is a significant cause of blindness worldwide, particularly when associated with glaucoma.
Direct damage from blunt or penetrating trauma, bleeding, inflammation, lens-related problems, orbital and brain vascular pathologies related to trauma, and chemical injuries may increase intraocular pressure and lead to traumatic glaucoma.
Treatment for traumatic glaucoma may involve simply eliminating the underlying cause in some conditions, but management can be challenging depending on the mechanism of damage.
If proper management for traumatic glaucoma is not undertaken, visual outcomes can be poor.
Related Articles5
Bilateral Acute Iris Transillumination and Elevated Intraocular Pressure After COVID-19 Infection.
Case SeriesIntravitreal fluocinolone acetonide 0.19 mg (Iluvien®) for the treatment of uveitic macular edema: 2-year follow-up of 20 patients.
Case SeriesExtended real-world experience with the ILUVIEN® (fluocinolone acetonide) implant in the United Kingdom: 3-year results from the Medisoft® audit study.
Observational StudyThe outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema.
Cohort StudyEffect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results.
Randomized Controlled TrialIs this article assigned to the wrong chapter(s)? Let us know.